Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404

PURPOSE: A prospective randomized clinical trial was conducted to evaluate the efficacy of tamoxifen plus doxorubicin and cyclophosphamide compared to tamoxifen plus tegafur-uracil as an adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC). METHODS: Eligibility criteria inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shien, Tadahiko, Iwata, Hiroji, Fukutomi, Takashi, Inoue, Kenichi, Aogi, Kenjiro, Kinoshita, Takayuki, Ando, Jiro, Takashima, Seiki, Nakamura, Kenichi, Shibata, Taro, Fukuda, Haruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143604/
https://www.ncbi.nlm.nih.gov/pubmed/25055938
http://dx.doi.org/10.1007/s00280-014-2545-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143604/
https://www.ncbi.nlm.nih.gov/pubmed/25055938
http://dx.doi.org/10.1007/s00280-014-2545-2

Ejemplares similares